NIFTP diagnostic and therapeutic approach

##plugins.themes.academic_pro.article.main##

Nadia Romdhane
Dorra Chiboub
Amira Khaldi
Jihene Gharsalli
Imen Zoghlami
Safa Nefzaoui
Ines Hariga
Chiraz Mbarek

Abstract

Background: Non-invasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) still spark controversy regarding histological diagnostic criteria and therapeutic management.


Aim: To elucidate the clinicopathological characteristics of NIFTP tumors and discuss their therapeutic management.


Methods: A retrospective study including 23 patients (26 nodules) operated on and followed up for NIFTP tumors according to the 2017 WHO classification over a 5-year period (January 2016-December 2020). The 2017 EUTIRADS classification was used for ultrasound nodule characterization. Fine-needle aspiration cytology was reported according to the 2017 Bethesda system.


Results: All patients were female, with a mean age of 47 years [19-71]. The average consultation delay was 9 months [2 months–7 years]. Thyroid nodules were incidentally discovered in 6 cases (26%). Examination revealed a solitary thyroid nodule in 20 cases. Nodules were classified as EUTIRADS III or IV in 82%. Fine-needle aspiration cytology, performed in 61% of cases, showed Bethesda III in 64% and IV in 14%. Total thyroidectomy was performed in 74%. Three cases of bifocal NIFTP were identified. Association with thyroid carcinoma was noted in 7 cases. No locoregional or distant recurrence was reported during a mean follow-up of 3 and a half years.


Conclusion: Recent revisions of NIFTP morphological criteria underscore the importance of strict adherence to inclusion and exclusion histo-morphological criteria.

Keywords:

Thyroid tumor, NIFTP, ultrasound, fine needle aspiration, surgery

##plugins.themes.academic_pro.article.details##

References

  1. Rossi ED, Faquin WC, Baloch Z, Fadda G, Thompson L, Larocca LM, et al. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Update and Diagnostic Considerations—a Review. Endocr Pathol. juin 2019;30(2):155‑62.
  2. Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LDR, et al. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol. 1 août 2016;2(8):1023.
  3. Jabeen S, Fatima S, Sheikh A, Islam N. Non Invasive Follicular Thyroid Neoplasm with Papillary like nuclear features (NIFTP), A time for change in Pakistan. Pak J Med Sci. 2020;36(2):151‑5.
  4. Bychkov A, Keelawat S, Agarwal S, Jain D, Jung CK, Hong S, et al. Impact of non-invasive follicular thyroid neoplasm with papillary-like nuclear features on the Bethesda system for reporting thyroid cytopathology: a multi-institutional study in five Asian countries. Pathology (Phila). juin 2018;50(4):411‑7.
  5. Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS. Eur Thyroid J. 2017;6(5):225‑37.
  6. Thompson LD. Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment. Mod Pathol Off J U S Can Acad Pathol Inc. juill 2016;29(7):698‑707.
  7. Al Hassan MS, El Ansari W, El Baba H, Petkar M, Abdelaal A. What you see might not be what you get: Analysis of 15 prospective cases of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Int J Surg Case Rep. févr 2022;91:106751.
  8. Turan G, Özkara SK. Pathological findings of the retrospective diagnosis of NIFTP (non-invasive follicular thyroid neoplasm with papillary-like nuclear features) in 84 cases from Turkey and systematic review. Ann Diagn Pathol. août 2021;53:151764.
  9. Yang GCH, Fried KO, Scognamiglio T. Sonographic and cytologic differences of NIFTP from infiltrative or invasive encapsulated follicular variant of papillary thyroid carcinoma: A Review of 179 Cases. Diagn Cytopathol. juin 2017;45(6):533‑41.
  10. Seo JY, Park JH, Pyo JY, Cha YJ, Jung CK, Song DE, et al. A Multi-institutional Study of Prevalence and Clinicopathologic Features of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP) in Korea. J Pathol Transl Med. nov 2019;53(6):378‑85.
  11. Jung CK, Bychkov A, Kakudo K. Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach. Endocrinol Metab. oct 2022;37(5):703‑18.
  12. Macerola E, Proietti A, Basolo F. Noninvasive follicular neoplasm with papillary-like nuclear features (NIFTP): a new entity. Gland Surg. janv 2020;9(Suppl 1):S47‑53.
  13. Legesse T, Parker L, Heath J, Staats PN. Distinguishing non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) from classic and invasive follicular-variant papillary thyroid carcinomas based on cytologic features. J Am Soc Cytopathol. 2019;8(1):11‑7.
  14. Lau RP, Paulsen JD, Brandler TC, Liu CZ, Simsir A, Zhou F. Impact of the Reclassification of « Noninvasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma » to « Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features » on the Bethesda System for Reporting Thyroid Cytopathology: A Large Academic Institution’s Experience. Am J Clin Pathol. 20 déc 2017;149(1):50‑4.
  15. Na HY, Park SY. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: its updated diagnostic criteria, preoperative cytologic diagnoses and impact on the risk of malignancy. J Pathol Transl Med. nov 2022;56(6):319‑25.
  16. Masson E. EM-Consulte. [cité 30 mai 2023]. Traitement par iode 131 des cancers thyroïdiens différenciés : recommandations 2017 des sociétés françaises SFMN/SFE/SFP/SFBC/AFCE/SFORL. Disponible sur: https://www.em-consulte.com/article/1136729
  17. Cho U, Mete O, Kim MH, Bae JS, Jung CK. Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Mod Pathol Off J U S Can Acad Pathol Inc. juin 2017;30(6):810‑25.
  18. Kim MJ, Won JK, Jung KC, Kim JH, Cho SW, Park DJ, et al. Clinical Characteristics of Subtypes of Follicular Variant Papillary Thyroid Carcinoma. Thyroid Off J Am Thyroid Assoc. mars 2018;28(3):311‑8.
  19. Parente DN, Kluijfhout WP, Bongers PJ, Verzijl R, Devon KM, Rotstein LE, et al. Clinical Safety of Renaming Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: Is NIFTP Truly Benign? World J Surg. févr 2018;42(2):321‑6.
  20. Nikiforov YE, Baloch ZW, Hodak SP, Giordano TJ, Lloyd RV, Seethala RR, et al. Change in Diagnostic Criteria for Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features. JAMA Oncol. 1 août 2018;4(8):1125.
  21. Xu B, Ghossein RA. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): An Update. Head Neck Pathol. juin 2020;14(2):303‑10.
  22. Eszlinger M, Lau L, Ghaznavi S, Symonds C, Chandarana SP, Khalil M, et al. Molecular profiling of thyroid nodule fine-needle aspiration cytology. Nat Rev Endocrinol. juill 2017;13(7):415‑24.
  23. Al Hassan MS, El Ansari W, Elshafeey A, Petkar M, Abdelaal A. First bilateral non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) co-occurring with bilateral papillary thyroid microcarcinoma. Case report and literature review. Int J Surg Case Rep. janv 2021;78:411‑6.
  24. Zhao L, Dias-Santagata D, Sadow PM, Faquin WC. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma. Cancer Cytopathol. mai 2017;125(5):323‑31.
  25. Chung R, Guan H, Ponchiardi C, Cerda S, Marwaha N, Yilmaz OH, et al. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Epidemiology and Long-Term Outcomes in a Strictly Defined Cohort. Thyroid Off J Am Thyroid Assoc. janv 2021;31(1):68‑75.
  26. Haugen BR, Sawka AM, Alexander EK, Bible KC, Caturegli P, Doherty GM, et al. American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. Thyroid Off J Am Thyroid Assoc. avr 2017;27(4):481‑3.
  27. Bongiovanni M, Faquin WC, Giovanella L, Durante C, Kopp P, Trimboli P. Impact of non-invasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTP) on risk of malignancy in patients undergoing lobectomy/thyroidectomy for suspected malignancy or malignant fine-needle aspiration cytology findings: a systematic review and meta-analysis. Eur J Endocrinol. oct 2019;181(4):389‑96.